Avita Medical Limited is an Australia-based medical device company. The Company's principal activity is commercialization of its regenerative product. It has three operating segments: the Asia Pacific region; the Americas, including Canada, and the Europe, Middle East and Africa (EMEA) region. It develops and distributes tissue-engineered products for the treatment of wound and other skin defects. The Company's lead product, ReCell Autologous Spray-On-Skin, enables the collection of healthy skin cells for immediate treatment of existing scars created by burns, skin grafts, acne, acute wounds or surgery, and skin discoloration, including leucoderma and vitiligo. Its Regenerative Epithelial Suspension (RES) has a range of applications and can be used to restart healing in unresponsive wounds, to repair burns using less donor skin, and to restore pigmentation and improve cosmesis of damaged skin.